Differentiating hereditary from nonhereditary retinoblastoma is now possible overnight, improving early intervention ...
In this study, we discover that DYRK1A interacts with TSC1 and TSC2. We show that DYRK1A phosphorylates TSC2 at T1462 and, therefore, is a possible positive regulator of mTORC1 activity and cell ...
This fundamental study identifies the kinase DYRK1A as a novel component of the tuberous sclerosis complex (TSC) protein complex, which is central to cellular growth and cell size. The findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback